Increasing Alzheimer’s Patients Spell Drug Profits

Some disturbing figures rolled out yesterday concerning growth rates of Alzheimer’s patients. The number of people affected grew 10% in the past four years and is expected to grow to over 115 million by 2050. That’s a doubling of cases every 20 years.

The number is expected to grow because of the diets and activity levels amongst older individuals in developed countries. Apparently we’re getting too much junk food and not enough exercise.

Numbers like that are scary to contemplate for many, especially families with relatives at risk, but they’re statistics that pharmaceutical companies love hearing.

Which is why we thought we’d pull up a few of the leading Alheimer’s drugs and the publicly listed companies that produce them: drugs like Aricept from Pfizer (NYSE: PFE), Exelon from Novartis AG ADR

...

Adeona Pharmaceuticals, Inc.

(Public, AMEX:AEN)

StocksHaven Investments takes a look at Adeona Pharmaceuticals, Inc. which currently has three blockbuster drugs in phase III, and are coming close to NDA status. The first being Trimesta, which tackles Multiple Sclerosis (MS) and Post-partum Depression. Secondly, Zinthionein, a product seeking treatment for Age Related Macular Degeneration (AMD). Lastly, Oral dnaJP1 which is an immunotherapy for rheumatoid arthritis (RA) patients. If these products aren’t enough to entice your way into purchasing this stock, take a look at the recent $5 million dollar cash infusion from the National Multiple Sclerosis Society (NMSS), billions of dollars in product market potential, purchasing of Hartlab LLC, an independent Chicago-area CLIA-certified clinical reference laboratory, an experienced management team that will have you feeling like a kid in a candy store, and to

...

PWRM, Power 3 Medical Products Inc, PWRM.OB

DrStockPick.com News Report!

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Appoints Medical Director

-Lourdes R. Bosquez, MD, PA Appointed New Medical Director for PWRM-

 

Friday August 28, 2009

************************************************************** Power3 Medical Products, Inc. Appoints Medical Director

Lourdes R. Bosquez, MD, PA Appointed New Medical Director for Power3 Medical Products, Inc.

Woodlands, TX, - (CRWENEWSWIRE ) Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced that Lourdes R. Bosquez, MD, PA, was appointed Medical Director of the Company.

Power3 Medical Products, Inc., a biotechnology company with diagnostic products for Alzheimer’s disease, Parkinson’s disease, Breast Cancer and other diseases, has secured the

...

PWRM, Power 3 Medical Products Inc, PWRM.OB

DrStockPick.com News Report!

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Appoints Medical Director

-Lourdes R. Bosquez, MD, PA Appointed New Medical Director for PWRM-

 

Thursday August 27, 2009

************************************************************** Power3 Medical Products, Inc. Appoints Medical Director

Lourdes R. Bosquez, MD, PA Appointed New Medical Director for Power3 Medical Products, Inc.

Woodlands, TX, - (CRWENEWSWIRE ) Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced that Lourdes R. Bosquez, MD, PA, was appointed Medical Director of the Company.

Power3 Medical Products, Inc., a biotechnology company with diagnostic products for Alzheimer’s disease, Parkinson’s disease, Breast Cancer and other diseases, has secured the

...

Las Vegas CRWENewswire.com is pleased to announce a stock highlight on Dana Resources (OTC.BB:DANR), Power3 Medical Products, Inc. (OTCBB:PWRM), NewMarket Technology, Inc. (Pinksheets:NWMT)

Dana Resources (OTC.BB:DANR), a US-based precious metals exploration and development company, is pleased to announce the initiation of the production program at its Collota gold deposit. Dana Resources currently owns and operates seven mining projects located in Peru’s most prolific mining regions.

About Dana Resources Dana Resources is a precious and base metals exploration company with offices in the United States and Peru. Dana’s management team possesses local knowledge, extensive international connections, a wealth of experience and technical expertise in mining, mining finance, exploration and production. Dana Resources has acquired a portfolio of gold, silver and other precious & base metal properties located in Peru’s most prolific mining regions. With Peru growing as a producer of gold, silver and other metals on the international market, Dana Resources is well

...

PWRM, Power 3 Medical Products Inc, PWRM.OB

DrStockPick.com News Report!

Dr Stock Pick HOT News & Alerts!

Power3 Medical Products, Inc. Appoints Medical Director

-Lourdes R. Bosquez, MD, PA Appointed New Medical Director for PWRM-

 

Wednesday August 26, 2009

************************************************************** Power3 Medical Products, Inc. Appoints Medical Director

Lourdes R. Bosquez, MD, PA Appointed New Medical Director for Power3 Medical Products, Inc.

Woodlands, TX, - (CRWENEWSWIRE - 08/26/09) Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), today announced that Lourdes R. Bosquez, MD, PA, was appointed Medical Director of the Company.

Power3 Medical Products, Inc., a biotechnology company with diagnostic products for Alzheimer’s disease, Parkinson’s disease, Breast Cancer and other diseases,

...

BKD, Brookdale Senior Living Inc.

XOHO, XO Holdings Inc, XOHO.OB

PennyOmega.com Watch List!

PennyOmega.com Watch List ! for Tuesday August 4, 2009

Our Picks at PennyOmega.com for Tuesday August 4, 2009 are:

**************************************************************

BKD, Brookdale Senior Living Inc.

BKD is a leading owner and operator of senior living communities throughout the United States.

BKD is committed to providing an exceptional living experience through properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents.

Currently BKD owns and operates independent living, assisted living, and dementia-care communities and continuing care retirement centers, with 546 communities in 35 states and the ability to serve approximately 52,000 residents.

**Today after Closing Bell, BKD reported

...

GTX Corp and Aetrex Worldwide, Inc. have entered into a platform test agreement with plans to collaborate on the development and mechanical engineering of GTX’s patented PLS (Position Location System) 2-way transceivers and software systems to track the location of “wandering” seniors afflicted with dementia.

“There are a growing number of seniors suffering from dementia and we know over 50% ‘wander’ without anyone’s knowledge of where they are and where they are heading,” stated Chris Walsh, an ex Nike executive and current COO of GTX Corp. “The shoe we intend on developing with Aetrex should help authorized family members, friends, or caretakers reduce their stress and anguish by enabling them to locate their loved ones instantly with the click of mouse from any desktop computer or mobile phone with internet access.”

“Five million Americans are afflicted with Alzheimer’s and this is estimated to grow to more than twenty million as the Boomer

...

Alzheimer’s Care Key to Healthcare Facilities Sector

by The Investment U Research Team

We’ve been talking about Sunrise Assisted Living (NYSE: SRZ) recently, and the potential for some of its competitors to become major threats in this sector. There are only a couple of contenders likely to step up and do just that…

Emeritus (NYSE: ESC) and Five Star Quality Care (NYSE: FVE) are the most likely candidates. These companies run assisted living and nursing home communities for the elderly.

Based on the market capitalization, Five Star is the most undervalued prospect here followed by Sunrise and Emeritus. But all are profitable organizations making their principals quite happy. And like sunrise, the biggest issues these companies face is control of their debt loads.

Now what you need to look at carefully is

...

Highlights include Pfizer Inc. (PFE), Teva Pharmaceuticals Industries, Ltd. (TEVA), Medivation, Inc. (MDVN), Wyeth (WYE) and Elan Corp. (ELN).Spending on the research and development of Alzheimer's Disease (AD) treatment and prevention has grown significantly over the last 20 years. The aging baby-boom generation has resulted in a larger population of people at risk for developing the disease.This, coupled with recent advances in developing drugs that address the underlying cause of the disease versus just treating its symptoms, have been the catalysts for the recent accelerated interest in AD research. Pfizer Inc. (PFE), through partnering arrangements, has been one of the leaders of these efforts.Pfizer, along with partner Eisai Co., co-promote Aricept (donepezil), the leading drug for the treatment of Alzheimer's Disease, which should post approximately $3 billion in sales in 2009. Aricept is a reversible acetylcholinesterase inhibitor that ...